Biotech & MedTech News
-
FendX Announces Issuance of a Patent in China to Protect REPELWRAP(TM) Film
November 1, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
-
Hemostemix’s 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease
October 30, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that Stem…
-
FendX’s Nanotechnology is Featured at Canadian Chemical Engineering Conference in Calgary, AB
October 30, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a nanotechnology company…
-
FendX Engages nanoComposix for Scale-Up Development of Its Spray Nanotechnology
October 26, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a…
-
Hemostemix Announces Amendment of its $2.5 Million 5 Year Convertible Debenture Issued on June 11, 2021, Resulting in an Expected Interest Saving of Approximately $570,000
October 23, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it…
-
Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
October 20, 2023 (Source) — Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage…
-
FendX to Present at the Hidden Gems Conference and Available for Investor Meetings
October 18, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
Zentek Completes Return on Investment Analysis for Canadian Healthcare System
October 17, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company…
-
Zentek Announces Voting Results of Annual and Special Meeting
October 10, 2023 (Source) — Zentek Ltd. (Nasdaq: ZTEK) (TSXV: ZEN) (“Zentek” or the “Company”), an intellectual property development…
-
Zentek Announces Successful Aptamer Testing for Longevity of Protection and Minimum Effective Dose
October 10, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
